Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Artivion, Inc. Common Stock (NY: AORT )

23.42 -0.07 (-0.30%)
Official Closing Price Updated: 7:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Artivion, Inc. Common Stock

< Previous 1 2 Next >
Forget Nancy Pelosi, This Democratic Senator Made Up To $55K Profit In Nearly 3 Weeks On This Medical Device Stock That's Lost 40% In Last 5 Years
Democratic Senator Tina Smith bought shares in a Georgia-based medical device maker on 2 days this month and the stock has spiked since then. 
Via Benzinga
Why American Eagle Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Shares of American Eagle Outfitters, Inc. (NYSE: AEO) declined during Tuesday’s session after the company reported third-quarter financial results. Net revenue rose 5% Y/Y to $1.30 billion, beating the... 
Via Benzinga
Agilent Posts Upbeat Results, Joins Burlington Stores, Hibbett And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones falling around 90 points on Tuesday. 
Via Benzinga
Topics Stocks
Exposures US Equities
A Congress Member Bought Up To $200K In Artivion Stock: Here's What You Need To Know
Via Benzinga
Earnings Preview: Artivion
Via Benzinga
Why Symbotic Shares Are Trading Higher By Around 22%; Here Are 20 Stocks Moving Premarket
Shares of Symbotic Inc. (NASDAQ: SYM) surged in pre-market trading after the company reported better-than-expected fourth-quarter sales results. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to start Tuesday trading with a breakdown of the biggest pre-market stock movers worth keeping an eye on this morning! 
Via InvestorPlace
Artivion: Q1 Earnings Insights
Via Benzinga
Earnings Scheduled For February 16, 2023
Companies Reporting Before The Bell • RELX (NYSE:RELX) is estimated to report earnings for its Fiscal Year 2022. • Coca-Cola Europacific (NASDAQ:CCEP) is expected to report earnings for its Fiscal Year... 
Via Benzinga
Under Armour To Rally Over 13%? Here Are 5 Other Price Target Changes For Friday
Via Benzinga
This Analyst Says Artivion's Sell Off Seems Overdone After Trial Halt
Via Benzinga
4 Analysts Have This to Say About Artivion
Artivion (NYSE:AORT) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Artivion Stock Plunges Apixaban Vs. Warfarin Trial Setback, Reaffirms Annual Guidance
Via Benzinga
This Senator Just Bought Up To $100K In Artivion Stock
The Office of Senator Tina Smith reported a purchase of Artivion (NYSE:AORT) stock on October 17, 2022. According to the October filing, the transaction was made on October 17, 2022. 
Via Benzinga
Oppenheimer Maintains Outperform Rating for Artivion: Here's What You Need To Know
Oppenheimer has decided to maintain its Outperform rating of Artivion (NYSE:AORT) and lower its price target from $35.00 to $25.00. Shares of Artivion are trading up 1.43% over the last 24 hours, at... 
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Gainers Golden Sun Education Group Limited (NASDAQ: GSUN) shares surged 92.1% to settle at $52.89 on Friday. 
Via Benzinga
Earnings Scheduled For February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers 
Via Benzinga
Why Shares Of Oil & Gas Companies Are Trading Lower, Here Are 62 Stocks Moving In Friday's Mid-Day Session
Gainers Kiromic BioPharma, Inc. (NASDAQ: KRBP) shares jumped 87% to $0.4791. Kiromic BioPharma, said on Sept. 15, that the company received letter from the Nasdaq that co. has been granted 180-day... 
Via Benzinga
$100 Invested In This Stock 20 Years Ago Would Be Worth $600 Today
Artivion (NYSE:AORT) has outperformed the market over the past 20 years by 1.64% on an annualized basis producing an average annual return of 9.19%. Currently, Artivion has a market capitalization of... 
Via Benzinga
US Stocks Open Lower; Dow Tumbles 400 Points
U.S. stocks traded lower this morning, with the Dow Jones dropping around 400 points on Friday. 
Via Benzinga
Artivion: Q2 Earnings Insights
Artivion (NYSE:AORT) reported its Q2 earnings results on Thursday, August 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion beat estimated earnings by... 
Via Benzinga
Recap of Wednesday's Biotech Catalysts - End of The Day Summary
Via Benzinga
Recap: Artivion Q4 Earnings
Artivion (NYSE:AORT) reported its Q4 earnings results on Thursday, February 17, 2022 at 04:05 PM. Here's what investors need to know about the announcement. Earnings Artivion missed estimated earnings... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 75 stocks made new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to hit a new 52-week high... 
Via Benzinga
Stocks That Hit 52-Week Highs On Thursday
On Thursday, 95 companies set new 52-week highs. Interesting Highlights From Today's 52-Week Highs: The largest company by market cap to break to a new 52-week high... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022
Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,... 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.